Group T11: Botulinum Toxin Injections
18 items with their schedule fees and Medicare benefits.
| Item | Fee | 75% | Out of hospital |
|---|---|---|---|
| 18350Intramuscular botulinum toxin injections for hemifacial spasm in patients aged 12+, covering all injections administered in a single treatment session. | $149.45 | $112.10 | $127.05 (85%) |
| 18351Botulinum toxin (Dysport) injection for hemifacial spasm in patients aged 18 years or over, covering all injections administered on a single day. | $149.45 | $112.10 | $127.05 (85%) |
| 18353Injection of botulinum toxin (Botox, Dysport, or Xeomin) for cervical dystonia treatment, including all injections administered on a single day. | $298.85 | $224.15 | $254.05 (85%) |
| 18354Botulinum toxin injection for dynamic equinus foot deformity from cerebral palsy in patients aged 2+ years, treating muscles of one functional activity supplied by one motor nerve, maximum 4 sets per day (max 2 per limb). | $149.45 | $112.10 | $127.05 (85%) |
| 18355Injection of incobotulinumtoxinA for chronic excessive drooling in patients aged 2+ years with neurological or neurodevelopmental disorders, including all injections given on the same day. | $149.45 | $112.10 | $127.05 (85%) |
| 18360Botulinum toxin injection for moderate to severe focal spasticity in adults with neurological disorder, as second-line or adjunctive therapy, targeting one functional muscle group; maximum 4 sets per day (2 per limb). | $149.45 | $112.10 | $127.05 (85%) |
| 18361Botulinum toxin injection for moderate to severe upper limb spasticity in cerebral palsy patients aged 2+, treating muscles of one functional activity supplied by one motor nerve, limited to 4 sets per day (max 2 per limb). | $149.45 | $112.10 | $127.05 (85%) |
| 18362Botulinum toxin injection for severe underarm sweating in patients aged 12+ who've failed topical aluminium chloride, not treated within 4 months, and limited to 2 occasions per year if previously treated. | $295.30 | $221.50 | $251.05 (85%) |
| 18365Botulinum toxin injection for moderate to severe upper limb spasticity after acute event in adults aged 18+, as second-line or adjunct therapy, max 4 sets per day (2 per limb), requiring prior treatment response if previously treated twice. | $149.45 | $112.10 | $127.05 (85%) |
| 18366Injection of botulinum toxin type A into eye muscles to treat strabismus (crossed eyes), including all injections in one session and EMG guidance, under anaesthesia. | $187.25 | $140.45 | $159.20 (85%) |
| 18368Injection of botulinum toxin type A for treating spasmodic dysphonia, covering all injections administered in a single day. | $319.60 | $239.70 | $271.70 (85%) |
| 18369Injection of botulinum toxin (Dysport or Xeomin) for unilateral blepharospasm in adults aged 18+, including all injections in a single session. | $53.90 | $40.45 | $45.85 (85%) |
| 18370Botulinum toxin type A injection for treating unilateral blepharospasm in patients aged 12 years or over, covering all injections administered on a single day. | $53.90 | $40.45 | $45.85 (85%) |
| 18372Botulinum toxin type A injection for bilateral blepharospasm in patients aged 12+, including all injections administered on a single day. | $149.45 | $112.10 | $127.05 (85%) |
| 18374Botulinum toxin injection (Dysport or Xeomin) for bilateral blepharospasm in adults aged 18+, covering all injections on a single day under anaesthesia. | $149.45 | $112.10 | $127.05 (85%) |
| 18375Intravesical botulinum toxin A injection via cystoscopy for neurogenic detrusor overactivity incontinence (MS, spinal cord injury, or spina bifida) in adults aged 18+ who failed anticholinergics (≥14 episodes/week) and can self-catheterise; repeatabl… | $275.15 | $206.40 | — |
| 18377Botox injections for chronic migraine in adults aged 18+ who've failed 3+ preventive medications and have ≥15 headache days/month (≥8 migraine days) for 6+ months; up to 2 treatments per year, or more if achieving ≥50% reduction in headache days afte… | $149.45 | $112.10 | $127.05 (85%) |
| 18379Intravesical botulinum toxin injection via cystoscopy for idiopathic overactive bladder incontinence in adults (≥18 years) inadequately controlled by ≥2 anticholinergics, requiring self-catheterisation ability; repeatable if ≥50% reduction achieved 6… | $275.15 | $206.40 | — |